From the American Academy of Ophthalmology
News from the FSO
Another special FSO member benefit allows you special access to download slides and recordings from the Masters in Ophthalmology 2012 Annual Meeting. Please click here to access the presentations. You will be prompted to login using your FSO username and password at the top right hand side of the page. If you cannot remember your community username or password, please contact Colleen Filbert at cfilbert@mdeye.org or you may call 904-998-0819.
From the American Academy of Ophthalmology
Physicians have an additional year, until Oct. 14, 2014, to transition from the ICD-9 coding system to ICD-10. The U.S. Department of Health and Human Services is delaying the mandatory transition in part because of the number of federal compliance burdens that physician practices face, including requirements of the Medicare electronic health record incentive program and upcoming penalties for not participating in the Physician Quality Reporting System.
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
Investigators tested a new index they developed that estimates glaucoma severity based on functional measurements obtained by SAP and structural assessment by SD-OCT. Subjects included glaucoma patients and healthy controls. The index performed significantly better than isolated measures of structure and function for diagnosing preperimetric and perimetric glaucoma as well as for discriminating disease stages. Archives of Ophthalmology, September 2012
The Academy is calling on members to help stop a Centers for Medicare and Medicaid Services proposal to cut reimbursement for 27 office-based eye codes when two diagnostic services are billed by the same physician on the same day for a patient. The CMS proposal would cut the technical component for the second and subsequent services by 25 percent. The Academy believes these arbitrary cuts would have a negative impact on Medicare beneficiaries’ access to high-quality care, and make it increasingly difficult for physicians to maintain a comprehensive private practice.
This prospective, double-masked study randomized 286 dry eye patients to receive a single drop of 1% or 3% diquafosol or placebo ophthalmic solutions, six times a day for six weeks. Diquafosol, a P2Y2 receptor agonist, promotes secretion of aqueous tears and mucins on the ocular surface. At four weeks, fluorescein corneal staining scores, rose bengal corneal and conjunctival staining scores, and dry eye syndrome scores improved significantly with both dosages of diquafosol compared to placebo.
|
The Centers for Disease Control and Prevention and the U.S. Food and Drug Administration are advising physicians to halt use of any product originating from the New England Compounding Center in Framingham, Mass. For ophthalmology practices, this would include Avastin, which NECC compounds for use in intravitreal injections. |
Pages
Upcoming Events
In the News...
